Tag: nyse:jnj

January 9, 2020

Kaleido Collaborates with Janssen on Metabolic Therapies

Kaleido announced a research collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson on metabolic therapies.
December 31, 2019

XBiotech Sells Human Antibody to Janssen for US$750 Million

XBiotech announced the closing of the sale of its True Human antibody Bermekimab to Johnson & Johnson's Janssen Biotech.
December 23, 2019

Pharma Trends 2019: FDA Approvals Make Waves Through Market

INN takes a look at the pharma trends of 2019 that have shaken up the space this year and created...
October 24, 2019

What Do Medical Device Companies Do?

Medical device companies facilitate the lives of doctors and patients by providing cutting-edge technology solutions.
September 12, 2019

5 Alzheimer’s Disease Treatment Stocks on the NASDAQ

A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
September 5, 2019

Investing in ADHD Treatments

The Investing News Network breaks down the key points you need to know about if you want to invest in...
August 28, 2019

10 Top Pharma Companies by Revenue

We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.